Twist Bioscience (TWST)
(Delayed Data from NSDQ)
$41.57 USD
+1.21 (3.00%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $41.22 -0.35 (-0.84%) 7:58 PM ET
4-Sell of 5 4
F Value A Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$41.57 USD
+1.21 (3.00%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $41.22 -0.35 (-0.84%) 7:58 PM ET
4-Sell of 5 4
F Value A Growth F Momentum C VGM
Zacks News
Twist Bioscience (TWST) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Twist Bioscience (TWST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is a Beat in the Cards for Twist (TWS) This Earnings Season?
by Zacks Equity Research
Investors will focus on the top-line and bottom-line numbers when Twist (TWST) reports fiscal second-quarter 2021 results.
Twist Bioscience (TWST) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Twist Bioscience (TWST) delivered earnings and revenue surprises of 2.70% and 11.47%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Twist Bioscience (TWST) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
by Zacks Equity Research
Twist Bioscience (TWST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
A Deep Dive into ARK ETFs
by Neena Mishra
We highlight the best performing ETFs managed by Cathie Wood
Will Twist Bioscience (TWST) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Twist Bioscience (TWST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Twist Bioscience (TWST) delivered earnings and revenue surprises of 6.94% and 56.89%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Will Twist Bioscience (TWST) Report Negative Q3 Earnings? What You Should Know
by Zacks Equity Research
Twist Bioscience (TWST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Twist Bioscience (TWST) delivered earnings and revenue surprises of -18.06% and 13.09%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Twist Bioscience (TWST) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
by Zacks Equity Research
Twist Bioscience (TWST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Twist Bioscience's Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Twist Bioscience.
Why Twist Bioscience (TWST) Stock Might be a Great Pick
by Zacks Equity Research
Twist Bioscience (TWST) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Twist Bioscience (TWST) Catches Eye: Stock Jumps 8%
by Zacks Equity Research
Twist Bioscience (TWST) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.
Twist Bioscience (TWST) Looks Good: Stock Adds 6.5% in Session
by Zacks Equity Research
Twist Bioscience (TWST) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.